Oxidative stress, inflammation, and cancer: how are they linked
Investors are clearly excited about a NASDAQ IPO by a biotech company developing a dual GLP-1/GIP agonist to treat obesity, which is scheduled for June 2025
Because this combination is not approved yet, healthcare providers will eventually closely monitor patients for gastrointestinal side effects, such as nausea, vomiting, or constipation, and adjust doses accordingly to maximize benefits while minimizing discomfort
Runny Nose or Sore Throat Less commonly, some users have reported cold-like symptoms such as a runny nose or sore throat
Institut Gustave Roussy, Paris
However, how well morning or evening doses work can depend on your routine, sleep habits, or how your digestive system reacts